Walleye Capital’s Avanos Medical AVNS Stock Holding History

Walleye Capital’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-5,200	Closed	-$227K	–	1897
2019 Q2	$227K	Buy	+5,200	New	+$222K	0.02%	898

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Walleye Capital's AVNS Position: Q1 2026 in Review

Walleye Capital sold out of Avanos Medical (AVNS) in Q1 2026, closing a stake of 39,848 shares — an estimated $447K sold.

Walleye Capital first reported a position in AVNS in Q3 2023 and held it in 6 quarters. The position peaked at $940K in Q1 2025. 257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.

Walleye Capital reported no remaining Avanos Medical position as of Q1 2026 after selling out during the quarter.
Walleye Capital sold 39,848 Avanos Medical shares in Q1 2026, an estimated $447K.
Walleye Capital first reported a position in Avanos Medical in Q3 2023 and held it in 6 quarters.
Walleye Capital's Avanos Medical position peaked at $940K in Q1 2025.
257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.